chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 1/27/21 lot# 007M20A;  Moderna 2/24/21 lot# 010A21A;  Moderna 10/27/21 lot# 939905;  MOderna 4/25/22 lot# 056M21A
Age: 65.0
Sex: F
Vaccine: FLUA4
Symptoms: Injection site reaction, Osteoarthritis, Pain, Tendonitis, X-ray limb abnormal
Clinical narrative: L deltoid distal tendonitis resulting in pain with shoulder extension, internal and external rotation. Improved but not resolved following 8 weeks of physical therapy.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines MOderna 2/8/21 lot# 037K20A;  Moderna 3/8/21 lot# 032H20A ; Pfizer 11/29/22 lot# GL0446
Age: 0.58
Sex: F
Vaccine: IPV
Symptoms: Hypersensitivity, Immunisation reaction, Urticaria
Clinical narrative: Pt Came back to office at 11:55 reporting allergic reaction to polio vaccine. Mother stated happened about 20 mins prior estimated 11:30am. Pt presented with Hives on face. Grabbed NP to assess. NP ordered Benadryl in office. Pt stayed for 20 minutes, Hives went away, gave Mother Nurse Advice Number and Mother stated she would call if anything more happened.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 11/18/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 89.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines Moderna 2/3/21 Lot# 038K20A;  Moderna 3/2/21 lot# 030A21A;  Moderna 10/26/21 lot# 939901;  Moderna 4/2/22 loT# 025L21B;  MOderna 10/4/22 lot# AS7162B
Age: 92.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Bacteraemia, COVID-19, Cystoscopy, Embolism venous
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED COVID POSITIVE, INCEDENTAL FINDING. PATIENT WAS ADMITTED D/T NEUTROPENIC FEVER D/T PROTEUS BACTEREMIA IN THE SETTING OF COMPLICATED UTI WITH OBSTRUCTIVE UROPATHY UNCOMPLICATED CYSTOSCOPY, UTEROSCOPY, LASER LITHO, AND STENT PLACEMENT COMPLETED ABX PER ID TEAM, UPPER EGD WITH REACTIVE GASTRITIS Atrial fibrillation with RVR (HCC),PROGRESSED TO SEPSIS.  Venous thromboemblism,  Neutropenic fever, Severe protein-calorie malnutrition, Pancytopenia, Ureteral calculus, Urinary tract infection due to Proteus. COVID 19 was not treated during admission.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Febrile neutropenia, Gastritis, Lithotripsy, Malnutrition, Oesophagogastroduodenoscopy abnormal
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED COVID POSITIVE, INCEDENTAL FINDING. PATIENT WAS ADMITTED D/T NEUTROPENIC FEVER D/T PROTEUS BACTEREMIA IN THE SETTING OF COMPLICATED UTI WITH OBSTRUCTIVE UROPATHY UNCOMPLICATED CYSTOSCOPY, UTEROSCOPY, LASER LITHO, AND STENT PLACEMENT COMPLETED ABX PER ID TEAM, UPPER EGD WITH REACTIVE GASTRITIS Atrial fibrillation with RVR (HCC),PROGRESSED TO SEPSIS.  Venous thromboemblism,  Neutropenic fever, Severe protein-calorie malnutrition, Pancytopenia, Ureteral calculus, Urinary tract infection due to Proteus. COVID 19 was not treated during admission.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pancytopenia, Proteus infection, SARS-CoV-2 test positive, Sepsis, Ureteral stent insertion
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED COVID POSITIVE, INCEDENTAL FINDING. PATIENT WAS ADMITTED D/T NEUTROPENIC FEVER D/T PROTEUS BACTEREMIA IN THE SETTING OF COMPLICATED UTI WITH OBSTRUCTIVE UROPATHY UNCOMPLICATED CYSTOSCOPY, UTEROSCOPY, LASER LITHO, AND STENT PLACEMENT COMPLETED ABX PER ID TEAM, UPPER EGD WITH REACTIVE GASTRITIS Atrial fibrillation with RVR (HCC),PROGRESSED TO SEPSIS.  Venous thromboemblism,  Neutropenic fever, Severe protein-calorie malnutrition, Pancytopenia, Ureteral calculus, Urinary tract infection due to Proteus. COVID 19 was not treated during admission.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ureterolithiasis, Ureteroscopy abnormal, Urinary tract infection, Urinary tract obstruction, Vaccine breakthrough infection
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED COVID POSITIVE, INCEDENTAL FINDING. PATIENT WAS ADMITTED D/T NEUTROPENIC FEVER D/T PROTEUS BACTEREMIA IN THE SETTING OF COMPLICATED UTI WITH OBSTRUCTIVE UROPATHY UNCOMPLICATED CYSTOSCOPY, UTEROSCOPY, LASER LITHO, AND STENT PLACEMENT COMPLETED ABX PER ID TEAM, UPPER EGD WITH REACTIVE GASTRITIS Atrial fibrillation with RVR (HCC),PROGRESSED TO SEPSIS.  Venous thromboemblism,  Neutropenic fever, Severe protein-calorie malnutrition, Pancytopenia, Ureteral calculus, Urinary tract infection due to Proteus. COVID 19 was not treated during admission.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, HIBV, MMRV, PNC13, VARCEL
Symptoms: Extra dose administered
Clinical narrative: Patient's mother was notified within an hour and no treatment was needed.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Colitis, Colitis ischaemic, Colonoscopy abnormal, Constipation
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED COVID POSITIVE. Severe proctocolitis in this patient who has been severely constipated; rule out Clostridium difficile colitis with severe leukemoid reaction. Colonoscopy path confirms Ischemic colitis 2. Coronavirus disease-2019, initially diagnosed on 08/14/2022. Leukocytosis. Remains with no particular treatment indicated for COVID-19 at this time.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Leukaemoid reaction, Leukocytosis, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED COVID POSITIVE. Severe proctocolitis in this patient who has been severely constipated; rule out Clostridium difficile colitis with severe leukemoid reaction. Colonoscopy path confirms Ischemic colitis 2. Coronavirus disease-2019, initially diagnosed on 08/14/2022. Leukocytosis. Remains with no particular treatment indicated for COVID-19 at this time.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Pt stated that after receiving his second dose of Pfizer on 04/16/2021, with in a couple of days he started with bad Headache's that lasted about a week.  He started with fatigue that was greater than normal and that has not gone away and he continue with Fatigue and gets tired easily doing everyday tasks.    He  has received three Pfizer monovalent and one Pfizer Bivalent vaccine.     First Dose = 03/26/2021, Second on 04/16/2021, Third 12/10/2021 and Fourth dose on 08/15/2022.  Only the last dose was given at our clinic. First two doses were from the Health Dept and third dose given at a pharmacy.   Report requested by Provider.
Age: 12.0
Sex: F
Vaccine: FLUA4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was given a flu vaccine that she had already received in December.  No adverse effects
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Symptom recurrence
Clinical narrative: CHRONIC RESPIRATORY FAILURE 9/22/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 12.0
Sex: F
Vaccine: HEPA
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Client received extra dose of hep A vaccine. No adverse effects noted after wait time of 15 minutes.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral artery occlusion, Cerebrovascular accident, Ischaemic stroke
Clinical narrative: ACUTE STROKE DUE TO OCCLUSION OF LEFT MIDDLE CEREBRAL ARTERY ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 2.5
Sex: F
Vaccine: DTAP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: pt recieved Dtap IM on 06/07/2023 but was not to receive the dose until 12/17/2024 per Health records
Age: 0.33
Sex: M
Vaccine: RV5
Symptoms: Intussusception, Respiratory symptom, Respiratory tract congestion, Ultrasound abdomen abnormal
Clinical narrative: Patient developed intestinal intussusception on 5/26/23 after vaccination on 5/19/23.   Of note, he also had the new onset of  upper respiratory symptoms the day prior to the event (5/25) but viral testing was not done.   I am not certain if the time frame fits the vaccination but I do know that there can be an association between the rotavirus vaccine and this condition which is why I am reporting it.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Respiratory failure, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY 1/9/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy rectum, Magnetic resonance imaging, Positron emission tomogram, Prostate cancer, Prostatic specific antigen
Clinical narrative: Prostate cancer, unknown when it started, doctor says it could be years. Diagnosed in May 2023.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Guillain-Barre syndrome, Hypoxia, Idiopathic partial epilepsy, Partial seizures, Status epilepticus
Clinical narrative: PARTIAL EPILEPSY GUILLAIN BARRE SYNDROME HYPOXIA EPILEPSY, PARTIAL IDIOPATHIC W STATUS EPILEPTICUS
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Myocardial ischaemia, Organ failure, Sepsis
Clinical narrative: DEMAND ISCHEMIA 3/27/2023 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION ACUTE RESPIRATORY FAILURE 3/27/2023 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION
Age: 0.5
Sex: M
Vaccine: MNQ
Symptoms: Vaccination error, Wrong product administered
Clinical narrative: Vaccine error: 5/24/23 I had asked Dr. what immunizations pt was due for. I sent her a list asking if he was due for Hib, PCV, dtap, polio and hep 3. Per doctor he was due for all 5. I confirmed with her again the list of immunizations and she stated yes those are the ones he is due for. At the time the patient was in office for his well child appt we had to call emergency services for pts mother due to her severe SOB. At that time I had stayed with the child and his father while EMS was taking care of pts mother. Pt, myself and pts father switched over to another room to give EMS some space to get pts mother on a stretcher to take her to the ER during this time CMA was helping gather the immunizations the pt needed while I was with pt and pts father in room 1. I confirmed the list with CMA the immunizations doctor had requested while I stayed in room 1 while she went to grab them.  Upon reconcile with RMA, office manager she noticed some immunizations missing upon reviewing pts immunizations given that day it appears pt was given all the correct vaccines except one. After RMA, myself and CMA reviewing vaccines looks like pt was given a meningococcal instead of PCV which meningococcal is not recommended until age 12. I did call and check on pt and his mother the next day which both was doing fine. I also reached out again the next week both still doing well.
Age: 11.0
Sex: F
Vaccine: HEPA
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Client received additional dose of Hep A vaccine and was observed for 15 minutes with no adverse effects noted.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Chest pain, End stage renal disease, Haemodialysis
Clinical narrative: ACUTE NON ST ELEVATION MI 4/19/2023 ACUTE NON ST ELEVATION MI    ESRD ON HEMODIALYSIS ACUTE NON ST ELEVATION MI 4/19/2023 CHEST PAIN ACUTE NON ST ELEVATION MI 4/19/2023 ACUTE NON ST ELEVATION MI
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Hypertension, Hypertonic bladder, Oral candidiasis
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED AND BOOSTED, COVID POSITIVE. PT DIAGNOSISED WITH Covid pneumonia,Hypertension on hydrochlorothiazide, AND Overactive bladder and urinary frequency. She otherwise denies any CP, SOB, fever, chills, diarrhea, focal neurological deficits, hallucinations, altered mental status or any other acute complaints.  Covid positive 8/23/22 treated with Paxlovid. Was prescribed Nystatin for oral thrush following her paxlovid, which she is no longer taking.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pollakiuria, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED AND BOOSTED, COVID POSITIVE. PT DIAGNOSISED WITH Covid pneumonia,Hypertension on hydrochlorothiazide, AND Overactive bladder and urinary frequency. She otherwise denies any CP, SOB, fever, chills, diarrhea, focal neurological deficits, hallucinations, altered mental status or any other acute complaints.  Covid positive 8/23/22 treated with Paxlovid. Was prescribed Nystatin for oral thrush following her paxlovid, which she is no longer taking.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anaemia, Cardiac failure congestive, Gastrointestinal haemorrhage, Lower gastrointestinal haemorrhage
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 ANEMIA ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 GI HEMORRHAGE ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 LOWER GI HEMORRHAGE ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 PERICARDIAL EFFUSION ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 PERICARDIAL EFFUSION
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Pericardial effusion
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 ANEMIA ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 GI HEMORRHAGE ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 LOWER GI HEMORRHAGE ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 PERICARDIAL EFFUSION ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 PERICARDIAL EFFUSION
Age: 12.0
Sex: M
Vaccine: HEPA, HPV9
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Client received additional dose of Hep A and HPV and was observed for 15 minutes after administration with no adverse effects observed.
Age: 11.0
Sex: F
Vaccine: TDAP
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Client received an additional dose of Tdap and was observed for 15 minutes post administration with no adverse effects noted.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: ALLERGIC REACTION, INIT
Age: 0.33
Sex: F
Vaccine: DTPPVHBHPB, PPV, RV1, DTPPVHBHPB, PPV, RV1
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: The patient was mistakenly administered Pneumovax23 which is not recommended for children under 2 years. Attempts have been made to contact parents, but I have not been able to reach them, so it is unknown if there has been an adverse effect.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization related to COVID 19 following completion of primary vaccine series
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Acute respiratory failure
Clinical narrative: ACUTE NON ST ELEVATION MI ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Diarrhoea, Feeling abnormal, Malaise, Vomiting
Clinical narrative: She got her vaccine, was perfectly fine when she got it, but a couple of hours later when she got home at 5:00 she started vomiting out of no where.  She just started and then started with diarrhea.  She had to get up with having to use the toilet last night, and she was feeling really rotten, and today she just does not feel good at all.  She does not know if this was connected with the vaccine or what, she has never connected the vaccines in the past with any AE.    Today she is having symptoms of feeling terrible.  She had to cancel 2 medical appointments today.  She is not running any fever, she has not had diarrhea since she got up at 12:00.  She did have some toast and a pot of tea, and she took her regular medicines when she got up and was able to hold that down.    She did not call her doctor, did call the pharmacy and spoke with Dr. who told her to call us and gave her our phone # and suggested that she call and report her reaction.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaemia, Anxiety, Asthenia, COVID-19, Cerebral small vessel ischaemic disease
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED WITH PFIZER COVID POSITIVE . 92 year old female  Admitted to the Hospital for Acute COVID, Dehydration, Hypokalemia, Hypernatremia, Thrombocytosis, Hypertension - Uncontrolled, Hyperlipidemia, CAD, Schizophrenia, Anemia, Anxiety, Dementia, and Weakness. PT PROGRESSED TO ASPIRATION PNUEMONIA, REQUIRED A PEG TUBE PLACEMENT DUE TO WEAKNESS AND CONFUSION.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head abnormal, Confusional state, Coronary artery disease, Dehydration, Dementia
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED WITH PFIZER COVID POSITIVE . 92 year old female  Admitted to the Hospital for Acute COVID, Dehydration, Hypokalemia, Hypernatremia, Thrombocytosis, Hypertension - Uncontrolled, Hyperlipidemia, CAD, Schizophrenia, Anemia, Anxiety, Dementia, and Weakness. PT PROGRESSED TO ASPIRATION PNUEMONIA, REQUIRED A PEG TUBE PLACEMENT DUE TO WEAKNESS AND CONFUSION.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypernatraemia, Hypertension, Hypokalaemia, Meningioma, Pneumonia aspiration
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED WITH PFIZER COVID POSITIVE . 92 year old female  Admitted to the Hospital for Acute COVID, Dehydration, Hypokalemia, Hypernatremia, Thrombocytosis, Hypertension - Uncontrolled, Hyperlipidemia, CAD, Schizophrenia, Anemia, Anxiety, Dementia, and Weakness. PT PROGRESSED TO ASPIRATION PNUEMONIA, REQUIRED A PEG TUBE PLACEMENT DUE TO WEAKNESS AND CONFUSION.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Schizophrenia, Thrombocytosis, Vaccine breakthrough infection
Clinical narrative: BREAKTHROUGH COVID: FULLY VACCINATED WITH PFIZER COVID POSITIVE . 92 year old female  Admitted to the Hospital for Acute COVID, Dehydration, Hypokalemia, Hypernatremia, Thrombocytosis, Hypertension - Uncontrolled, Hyperlipidemia, CAD, Schizophrenia, Anemia, Anxiety, Dementia, and Weakness. PT PROGRESSED TO ASPIRATION PNUEMONIA, REQUIRED A PEG TUBE PLACEMENT DUE TO WEAKNESS AND CONFUSION.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Monovalent mRNA vaccine administered for a bivalent mRNA dose.  I hadn't been made aware that the monovalent vaccine had had it's EUA revoked by the FDA at the time of this vaccines administration..  My supervisor received e-mail notification from our health department on 05/02/2023 with a Department of Health and Human Services update for immediate release to Covid-19 vaccines. This update simply stated that individuals that were previously vaccinated with monovalent Covid-19 vaccines and who had not received a dose of Bivalent vaccine could receive a single dose of bivalent vaccine.   The press release/ immediate release (dated 05/01/2023) did NOT state that the EUA had been revoked  on 04/18/2023.  I received the e-mail forwarded to me  on 05/03/2023 which I then destroyed the remaining MDV of Pfizer monovalent Lot FP7136 vaccine.   This patient did NOT suffer any type of adverse reaction or event.    This patient was notified of this occurrence but declined  the bivalent vaccine when offered.   This patient was released from custody on 05/20/2023.
Age: 43.0
Sex: F
Vaccine: HPV9
Symptoms: Vaccination site erythema, Vaccination site nodule, Vaccination site pain, Vaccination site warmth
Clinical narrative: Swollen knot on arm and red area underneath vaccination site.  Warm to touch, and patient reports it as painful.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Congenital neuropathy, Symptom recurrence
Clinical narrative: HEREDITARY PERIPHERAL NEUROPATHY 2/21/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Pyrexia
Clinical narrative: HYPOTENSION 4/14/2023 FEVER
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Monovalent mRNA vaccine administered for a bivalent mRNA dose.  I hadn't been made aware that the monovalent vaccine had had it's RA revoked by the FDA at the time of this vaccines administration..  My supervisor received e-mail notification from our county health department on 05/02/2023 with a update for immediate release to Covid-19 vaccines. This update simply stated that individuals that were previously vaccinated with monovalent Covid-19 vaccines and who had not received a dose of Bivalent vaccine could receive a single dose of bivalent vaccine.   The press release/ immediate release (dated 05/01/2023) did NOT state that the RA had been revoked  on 04/18/2023.  I received the e-mail forwarded to me  on 05/03/2023 which I then destroyed the remaining MDV of Pfizer monovalent Lot FP7136 vaccine.   This patient did NOT suffer any type of adverse reaction or event.    This patient was notified of this occurrence but declined  the bivalent vaccine when offered.   This patient was released from our custody and extradited to County Sheriff Office, on 05/11/2023.
Age: 22.0
Sex: U
Vaccine: MNQ, TDAP
Symptoms: Vaccination error
Clinical narrative: Outreach vaccination event at School.  20 MCV4 and 20 Tdap vaccines were taken to the event. Upon return to the Health Department clinic there was 5 Tdap and 8 MCV4 that were leftover. 14 students were vaccinated with both vaccines. Upon review of the vaccine inventory taken to this outreach event and the total number of students vaccinated, an error occurred.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Hypotension
Clinical narrative: ACUTE DVT, UNSPECIFIED VEIN 1/19/2023 HYPOTENSION HYPOTENSION 3/25/2023 HYPOTENSION
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Bacteraemia, Dysphagia, Dyspnoea, Melaena
Clinical narrative: ACUTE NON ST ELEVATION MI 4/6/2023 DYSPNEA ACUTE NON ST ELEVATION MI 4/6/2023 BACTEREMIA ACUTE NON ST ELEVATION MI 4/6/2023 MELENA ACUTE NON ST ELEVATION MI 4/6/2023 DYSPHAGIA
Age: 0.75
Sex: F
Vaccine: DTAP, HIBV, IPV
Symptoms: Blister, Erythema, Irritability, Oral mucosal eruption
Clinical narrative: Patient came in next day with dad due to rash around mouth. States started 30 mins after vaccination. Redness all around mouth and then bullae formed later in evening. Otherwise fussy but well. Progressed and called on call 24 hrs later with worsening rash.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Expired vaccine by 2 days
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Febrile convulsion
Clinical narrative: Febrile seizure, lasted a few minutes.  No prior history of febrile seizures.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Pt c/o no symptoms at the time of injection. To be further monitored.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Monovalent mRNA vaccine administered for a bivalent mRNA dose.  I hadn't been made aware that the monovalent vaccine had had it's EUA revoked by the FDA at the time of this vaccines administration..  My supervisor received e-mail notification from our county health department on 05/02/2023 with an update for immediate release to Covid-19 vaccines. This update simply stated that individuals that were previously vaccinated with monovalent Covid-19 vaccines and who had not received a dose of Bivalent vaccine could receive a single dose of bivalent vaccine.   The press release/ immediate release (dated 05/01/2023) did NOT state that the EUA had been revoked  on 04/18/2023.  I received the e-mail forwarded to me  on 05/03/2023 which I then destroyed the remaining of Pfizer monovalent Lot FP7136 vaccine.   This patient did NOT suffer any type of adverse reaction or event.     This  patient  was notified of event and is scheduled to receive the Pfizer Bivalent vaccine on 06-09-2023.
Age: 57.0
Sex: M
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: This was not and event with adverse reaction.  This was an event due to the patient being under the age of 65.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Monovalent mRNA vaccine administered for a bivalent mRNA dose.  I hadn't been made aware that the monovalent vaccine had had it's EUA revoked by the FDA at the time of this vaccines administration..  My supervisor received e-mail notification from our health department on 05/02/2023 with a Department of Health and Human Services update for immediate release to Covid-19 vaccines. This update simply stated that individuals that were previously vaccinated with monovalent Covid-19 vaccines and who had not received a dose of Bivalent vaccine could receive a single dose of bivalent vaccine.   The press release/ immediate release (dated 05/01/2023) did NOT state that the EUA had been revoked  on 04/18/2023.  I received the e-mail forwarded to me  on 05/03/2023 which I then destroyed the remaining MDV of Pfizer monovalent Lot FP7136 vaccine.   This patient did NOT suffer any type of adverse reaction or event.    This patient was notified of this occurrence .  On 05/17/2023 this patient WAS given Pfizer Bivalent vaccine Lot GJ3270 with exp 01/31/24 in right deltoid. Tolerated well! This patent was released from our custody on 05/18/2023.
Age: 1.33
Sex: M
Vaccine: DTAP
Symptoms: Cellulitis, Crying, Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Mother called into clinic on 6/3 due to patient "crying" most of the night and when he woke on 6/3 his left thigh was hard, swollen and red. Patient did not have a fever. As the day progressed redness on patient's thigh spread and it was hot to the touch. Mother reports that patient cried if anyone touched his thigh. Patient was taken to Emergency Department and was diagnosed with cellulitis and prescribed antibiotics. RN saw patient on 6/6 and redness had improved. Photos were taken and uploaded into the chart. It appears that vaccine was given in middle of thigh and not laterally.
Age: 1.33
Sex: M
Vaccine: DTAP
Symptoms: Injection site warmth
Clinical narrative: Mother called into clinic on 6/3 due to patient "crying" most of the night and when he woke on 6/3 his left thigh was hard, swollen and red. Patient did not have a fever. As the day progressed redness on patient's thigh spread and it was hot to the touch. Mother reports that patient cried if anyone touched his thigh. Patient was taken to Emergency Department and was diagnosed with cellulitis and prescribed antibiotics. RN saw patient on 6/6 and redness had improved. Photos were taken and uploaded into the chart. It appears that vaccine was given in middle of thigh and not laterally.
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cardiac arrest, Cardio-respiratory arrest, Death
Clinical narrative: patient coded with cardiac arrest; patien passed
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Obstructive sleep apnoea syndrome
Clinical narrative: G47.33 OBSTRUCTIVE SLEEP APNEA 4/25/2023 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE G47.33 OBSTRUCTIVE SLEEP APNEA 4/25/2023 CHRONIC ATRIAL FIBRILLATION
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Aortic arteriosclerosis, End stage renal disease, Hypoxia
Clinical narrative: Pfizer vaccine was administered outside of facility - reported by patient- ? NO LOT NUMBER WERE SUPPLIED -------------------------------------------------------------------------------------------------------------------------- R09.02 HYPOXIA 3/24/2023 ATHEROSCLEROSIS OF AORTA ESRD (END STAGE RENAL DISEASE)
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Loss of consciousness, Road traffic accident
Clinical narrative: Later on in the dat at about 330pm pt was driving and "blacked out" causing a MVA.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Cytomegalovirus colitis, Deep vein thrombosis
Clinical narrative: ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 4/11/2023 CMV COLITIS
Age: 38.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Abdominal pain upper, Chest pain, Dyspnoea exertional, Feeling of body temperature change, Hypoaesthesia
Clinical narrative: Actually, I am having quite a few reactions that are abnormal for me that I did not have before the shots.  I went to the doctor on Friday for a yearly physical and she found a supraclavicular lymph node swelling on the right clavicle that I now have to get ultra-sounded on June 26th.  The vaccines kicked my butt, especially the one given in the right arm.  The night of and the couple of days after I have been sick with malaise, arm tingling and numbness, slight chest pain and exertion breathing issues/ stomach pain and having issues thermoregulating at night.  I have had like almost cold flashes and then will get really hot and have been having issues sleeping.  I had a slight fever the day of, but haven't had any since, but the arm numbness, stomach pain and swollen node are not abating and it is now Saturday.   I feel like I need to report this and I don't know how to go about it.  My doctor was really worried about the clavicle node until I told her I just had a vaccine a day and a half before but she  said it is soft, moveable and tender which is a good sign it's vaccine related, but still needs me to be seen for it.  I looked up side effects and adverse reactions on the web and these are all part of the B vaccine affects, but I'm wondering if I should be seen in ER, because some of them are kind of freaking me out obviously because you don't mess around with supraclavicular node issues.
Age: 38.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Insomnia, Lymphadenopathy, Malaise, Paraesthesia, Pyrexia
Clinical narrative: Actually, I am having quite a few reactions that are abnormal for me that I did not have before the shots.  I went to the doctor on Friday for a yearly physical and she found a supraclavicular lymph node swelling on the right clavicle that I now have to get ultra-sounded on June 26th.  The vaccines kicked my butt, especially the one given in the right arm.  The night of and the couple of days after I have been sick with malaise, arm tingling and numbness, slight chest pain and exertion breathing issues/ stomach pain and having issues thermoregulating at night.  I have had like almost cold flashes and then will get really hot and have been having issues sleeping.  I had a slight fever the day of, but haven't had any since, but the arm numbness, stomach pain and swollen node are not abating and it is now Saturday.   I feel like I need to report this and I don't know how to go about it.  My doctor was really worried about the clavicle node until I told her I just had a vaccine a day and a half before but she  said it is soft, moveable and tender which is a good sign it's vaccine related, but still needs me to be seen for it.  I looked up side effects and adverse reactions on the web and these are all part of the B vaccine affects, but I'm wondering if I should be seen in ER, because some of them are kind of freaking me out obviously because you don't mess around with supraclavicular node issues.
Age: 38.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Temperature regulation disorder
Clinical narrative: Actually, I am having quite a few reactions that are abnormal for me that I did not have before the shots.  I went to the doctor on Friday for a yearly physical and she found a supraclavicular lymph node swelling on the right clavicle that I now have to get ultra-sounded on June 26th.  The vaccines kicked my butt, especially the one given in the right arm.  The night of and the couple of days after I have been sick with malaise, arm tingling and numbness, slight chest pain and exertion breathing issues/ stomach pain and having issues thermoregulating at night.  I have had like almost cold flashes and then will get really hot and have been having issues sleeping.  I had a slight fever the day of, but haven't had any since, but the arm numbness, stomach pain and swollen node are not abating and it is now Saturday.   I feel like I need to report this and I don't know how to go about it.  My doctor was really worried about the clavicle node until I told her I just had a vaccine a day and a half before but she  said it is soft, moveable and tender which is a good sign it's vaccine related, but still needs me to be seen for it.  I looked up side effects and adverse reactions on the web and these are all part of the B vaccine affects, but I'm wondering if I should be seen in ER, because some of them are kind of freaking me out obviously because you don't mess around with supraclavicular node issues.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Poor quality sleep, Rhinorrhoea
Clinical narrative: In the evening I noticed my nose was running and I was very tired with a cough.  I had fitful sleep that evening.  This was just returning from a trip.  5/12 Symptoms stayed about the same.  5/13 I had overwhelming fatigue and tested with an At Home COVID-19 Test.  Positive results.  5/15 Talked to doctor who proscribed Paxlovid.  When I started taking Paxlovid, the fatigue and the runny nose really diminished.  By 5/17 I felt much better, the nose had stopped running and there was very little coughing.  Symptoms got gradually better until 5/22 I was felling recovered.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: In the evening I noticed my nose was running and I was very tired with a cough.  I had fitful sleep that evening.  This was just returning from a trip.  5/12 Symptoms stayed about the same.  5/13 I had overwhelming fatigue and tested with an At Home COVID-19 Test.  Positive results.  5/15 Talked to doctor who proscribed Paxlovid.  When I started taking Paxlovid, the fatigue and the runny nose really diminished.  By 5/17 I felt much better, the nose had stopped running and there was very little coughing.  Symptoms got gradually better until 5/22 I was felling recovered.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Ischaemic stroke
Clinical narrative: I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 3/31/2023 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Fatigue, Hyperhidrosis, Pain, Pyrexia
Clinical narrative: Patient reports that he had fairly sudden onset of Fever of 103, sweating, fatigue, generalized aching approximately by 5 pm that day. He was weak.
Age: 2.0
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Wrong product administered
Clinical narrative: Patient was given incorrect vaccines. Did not show and verbalized having any adverse effects. Patient was given an appointment to follow up with provider if any concerns or reactions.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Aortic valve stenosis, Cellulitis, Sleep apnoea syndrome
Clinical narrative: Moderna vaccine was administered outside of source - reported by patient ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------------------- G47.30 SLEEP APNEA 3/29/2023 AORTIC VALVE STENOSIS G47.30 SLEEP APNEA 3/29/2023 CELLULITIS G47.30 SLEEP APNEA 3/29/2023 HX OF HEMORRHAGIC STROKE W UNSPECIFIED RESIDUAL DEFICITS
Age: 17.0
Sex: M
Vaccine: UNK
Symptoms: No adverse event
Clinical narrative: No adverse reaction, no treatment needed due to no adverse reaction.
Sex: F
Vaccine: HPV4, HPV9
Symptoms: Papilloma viral infection
Clinical narrative: she was diagnosed with Type 18 HPV.; This spontaneous report was received from a nurse via company representative referring to herself, a female patient of unknown age. Information of concurrent conditions, pertinent medical history, concomitant medications and drug reactions or allergies was not reported.  On an unknown date, the patient was vaccinated with the Company unidentified human papillomavirus (HPV) vaccine (the patient not sure it was hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)) (strength, dose, lot#, expiration date, route and anatomical location were not provided) for prophylaxis.  On an unknown date (a year or so later), the patient was diagnosed with type 18 HPV (papilloma viral infection). Action taken with suspect vaccines for the event was not applicable. The outcome of the event was not reported.   The causality assessment between the suspect vaccines and event papilloma viral infection was not provided.
Sex: M
Vaccine: HPV9
Symptoms: No adverse event, Product dose omission issue
Clinical narrative: he had missed his second dose of GARDASIL 9 in a 3 dose series.; This spontaneous report was received from a the patient regarding himself, a male of unspecified age and race. His medical history , historical drugs, known allergies, concurrent conditions, and concomitant therapies were not reported.  On an unspecified date, the patient was vaccinated with the first dose of with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, lot #, expiry date, and route of administration were not provided) in a three dose series. On 07-MAY-2023, the patient missed his second dose of this suspect vaccine in a 3 dose series (Vaccine dose omission). No further information or adverse events were provided.
Sex: M
Vaccine: RV5
Symptoms: Expired product administered
Clinical narrative: Confirmed that no symptomatic adverse events were reported/No additional AE; Administration of ROTATEQ that was expired to two patients; This spontaneous report was received from an office manager referring to a 4-months-old male patient. The patient's pertinent medical history, concomitant medications, and drug reactions or allergies were not reported.  On 30-MAY-2023, the patient received the first dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) vial 2 mL, once, orally, lot number: U038863 was verified to be a valid lot number for Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), expiration date was provided and upon internal validation was confirmed to be: 27-MAY-2023 (expired product administered) administered as prophylaxis. It was confirmed that no symptomatic adverse events were reported (No adverse event). Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) did not have any previous temperature excursion outside recommended range in the past.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2306USA000682:
Sex: U
Vaccine: HEP
Symptoms: Hepatitis B antibody negative, No adverse event
Clinical narrative: HCP reported an 18-year-old patient who has already received 3 doses of RECOMBIVAX HB but is non-reactive on an antibody test.; This spontaneous report was received from a physician referring to a 18-year-old patient of unknown gender. The patient's pertinent medical history, drug react6ions/allergies, concurrent conditions and concomitant medications were not reported.       On unknown dates, the patient received 3 doses of hepatitis b vaccine (recombinant)(RECOMBIVAX HB) for prophylaxis (strength, dose, frequency, route of administration, lot # and expiration date were not reported). It was stated that the patient was non-reactive on an antibody test (hepatitis b antibody negative). No additional adverse event (AE) was reported. At the time of reporting, the outcome of the event was unknown.  The causality assessment between the event and hepatitis b vaccine (recombinant)(RECOMBIVAX HB) was not provided.
Sex: U
Vaccine: HPV9
Symptoms: No adverse event, Product storage error
Clinical narrative: No Adverse Event; Nurse reported AE for improperly stored administered GARDASIL 9. Declined full patient demographics. No additional AE/PQC.; This spontaneous report was received from an other health professional refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 02-JUN-2023, the patient was vaccinated with improper storage hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot #w013388, expiration date: 16-DEC-2024 (exact dose, route of administration and anatomical location were not reported) for prophylaxis.  Administered dose of vaccine was exposed to the temperature excursion (product storage error).  There were no additional adverse events reported (no adverse event).  This is one of several reports received from the same reporter ; Sender's Comments:  US-009507513-2306USA003055:
Sex: U
Vaccine: HEP
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; Patient received a dose of the RECOMBIVAX HB vaccine that was improperly stored.; This spontaneous report was received from other health proffesional and refers to a patient of unknown age. No information on patient's medical history, current conditions and concomitant medications was provided.      On 23-MAY-2023 the patient was vaccinated with dose of improperly stored hepatitis b vaccine (recombinant) (RECOMBIVAX HB) lot # W012032 and expiration date 19-NOV-2023 for prophylaxis (exact dose, frequency and route of administration were not provided) (product storage error and no adverse event). ; Sender's Comments:  US-009507513-2306USA003084:
Sex: U
Vaccine: VARCEL
Symptoms: Product storage error
Clinical narrative: No additional AE; patient was administered an improperly stored vaccine; This spontaneous report was received from Other and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided).  On 02-JUN-2023, the patient was administered an improperly stored vaccine. HBP provided limited pertinent information. Permission was provided to contact the HCP. No additional AE/PQC reported.
Sex: F
Vaccine: MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: adult patient was administered PROQUAD by accident.; No Adverse Event; This spontaneous report was received from a nurse refers to a 70-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 06-JUN-2023, the patient was vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous (lot #, expiration date, exact dose, and anatomical location were not reported) for prophylaxis.  It was reported, that an adult patient was administered measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) by accident (product administered to patient of inappropriate age). No additional adverse event reported (no adverse event).
Sex: U
Vaccine: HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; Patient received a dose of the VAQTA vaccine that was improperly stored.; This spontaneous report was received from an other healthcare professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/allergies was not provided.  On 23-MAY-2023, the patient was vaccinated with improperly stored dose of hepatitis A vaccine, inactivated (VAQTA) intramuscular injection (formulation pre-filled syringe, lot #X004813, expiration date 28-JUL-2024, exact dose, route of administration and anatomical location were not provided) for prophylaxis (Product storage error).  On unknown day, the suspect vaccine experienced a temperature excursion. No additional adverse events (AEs) or product quality complaints (PQC) were reported (No adverse event).  This is one of two reports from the same reporter. ; Sender's Comments:  US-009507513-2306USA003052:
Sex: F
Vaccine: VARCEL
Symptoms: Exposure during pregnancy
Clinical narrative: Physician reported AE for patient who received VARIVAX while pregnant; patient is asymptomatic. Patient received VARIVAX on 5/25/2023 and physician was made aware of her pregnancy on 06/01/2023. Physician declined to be contacted for further AE detai; No adverse event; This spontaneous report was received from Physician and refers to a female of unknown age.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 25-MAY-2023, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) injection, 1 dose, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided).  On an unknown date, the physician reported AE for patient who received VARIVAX while pregnant; patient is asymptomatic. On 01-JUN-2023, physician was made aware of her pregnancy. Physician declined to be contacted for further AE details. No additional AE/PQC.
Sex: U
Vaccine: VARCEL
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; HCP calling to report an AE regarding the VARIVAX vaccine. HCP reported that the patient received an expired dose of VARIVAX. Request case 02402383 filed. Permission was provided to contact the HCP. No additional AE/PQC reported.; This spontaneous report was received from Consumer and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, lot #U015686, expiration date: 18-MAY-2023 (strength, route of administration, and indication were not provided).  On 06-JUN-2023, HCP called to report an AE regarding the varicella virus vaccine live (oka/merck) (VARIVAX) vaccine. HCP reported that the patient received an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX). Request case 02402383 filed. Permission was provided to contact the HCP. No additional AE/PQC reported.
Sex: U
Vaccine: MMR
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; Nurse reported AE for improperly stored administered MMRII. Declined full patient demographics. No additional AE/PQC.; This spontaneous report was received from Other Health Professional and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 30-MAY-2023, the patient started therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, 1 dose, lot #W034592, expiration date: 10-MAY-2024, administered for prophylaxis (strength, and route of administration were not provided).  On 30-MAY-2023, nurse reported AE for improperly stored administered measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II). Declined full patient demographics. No additional AE/PQC.